Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)
Boris V. Janssen(Amsterdam University Medical Centers), Angela Chou(Royal North Shore Hospital), Noriyoshi Fukushima(Jichi Medical University), Marc G. Besselink(Amsterdam Neuroscience), Caroline S. Verbeke(Oslo University Hospital), Aatur D. Singhi(University of California, San Francisco), Volkan Adsay(Koç University), Susan van Dieren(Amphia Ziekenhuis), Alyssa Krasinkas(Emory University), Elizabeth A. Thompson(North Carolina State University), Anthony J. Gill(The University of Sydney), Jeffrey Kaplan(University of Colorado Hospital), Lodewijk A.A. Brosens(Utrecht University), Stijn van Roessel(Amsterdam University Medical Centers), Joanne Verheij, Claudio Doglioni(Vita-Salute San Raffaele University), Talia L. Fuchs(The University of Sydney), Arantza Fariña Sarasqueta(Leiden University), Claudio Luchini(University of Verona), Chanjuan Shi(Duke University Health System), Roger Feakins(Royal Free London NHS Foundation Trust), Iréne Esposito(Heinrich Heine University Düsseldorf), Seung‐Mo Hong(Ulsan College), Deyali Chatterjee(The University of Texas MD Anderson Cancer Center), Marie‐Louise F. van Velthuysen(Erasmus MC), Olca Baştürk(Memorial Sloan Kettering Cancer Center), Onno J. de Boer(Amsterdam University Medical Centers), Huamin Wang(The University of Texas MD Anderson Cancer Center), Ralph H. Hruban(Johns Hopkins University), Fiona Campbell(University of Birmingham)
Cited by 27
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k